Literature DB >> 32185899

Why is Listeria monocytogenes such a potent inducer of CD8+ T-cells?

Alfredo Chávez-Arroyo1, Daniel A Portnoy2,3.   

Abstract

Listeria monocytogenes is a rapidly growing, Gram-positive, facultative intracellular pathogen that has been used for over 5 decades as a model to study basic aspects of infection and immunity. In a murine intravenous infection model, immunisation with a sublethal infection of L. monocytogenes initially leads to rapid intracellular multiplication followed by clearance of the bacteria and ultimately culminates in the development of long-lived cell-mediated immunity (CMI) mediated by antigen-specific CD8+ cytotoxic T-cells. Importantly, effective immunisation requires live, replicating bacteria. In this review, we summarise the cell and immunobiology of L. monocytogenes infection and discuss aspects of its pathogenesis that we suspect lead to robust CMI. We suggest five specific features of L. monocytogenes infection that positively impact the development of CMI: (a) the bacteria have a predilection for professional antigen-presenting cells; (b) the bacteria escape from phagosomes, grow, and secrete antigens into the host cell cytosol; (c) bacterial-secreted proteins enter the major histocompatibility complex (MHC) class I pathway of antigen processing and presentation; (d) the bacteria do not induce rapid host cell death; and (e) cytosolic bacteria induce a cytokine response that favours CMI. Collectively, these features make L. monocytogenes an attractive vaccine vector for both infectious disease applications and cancer immunotherapy.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  bacteria; cancer; dendritic cell; inflammasome; intracellular pathogen; macrophage; tumour; vaccine

Mesh:

Substances:

Year:  2020        PMID: 32185899      PMCID: PMC7100999          DOI: 10.1111/cmi.13175

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  97 in total

Review 1.  Virus-encoded homologs of cellular interleukin-10 and their control of host immune function.

Authors:  Barry Slobedman; Peter A Barry; Juliet V Spencer; Selmir Avdic; Allison Abendroth
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

2.  Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen.

Authors:  Tracy L McGaha; Yunying Chen; Buvana Ravishankar; Nico van Rooijen; Mikael C I Karlsson
Journal:  Blood       Date:  2011-03-28       Impact factor: 22.113

3.  Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity.

Authors:  P Berche; J L Gaillard; P J Sansonetti
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

4.  Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity.

Authors:  John-Demian Sauer; Sabine Pereyre; Kristina A Archer; Thomas P Burke; Bill Hanson; Peter Lauer; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 5.  The STING controlled cytosolic-DNA activated innate immune pathway and microbial disease.

Authors:  Hiroyasu Konno; Glen N Barber
Journal:  Microbes Infect       Date:  2014-10-18       Impact factor: 2.700

6.  Generation of a Listeria vaccine strain by enhanced caspase-1 activation.

Authors:  Sarah E Warren; Hien Duong; Dat Phat Mao; Abraham Armstrong; Jayant Rajan; Edward A Miao; Alan Aderem
Journal:  Eur J Immunol       Date:  2011-06-08       Impact factor: 5.532

7.  The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen.

Authors:  Taiki Aoshi; Javier A Carrero; Vjollca Konjufca; Yukio Koide; Emil R Unanue; Mark J Miller
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

Review 8.  Listeria monocytogenes - from saprophyte to intracellular pathogen.

Authors:  Nancy E Freitag; Gary C Port; Maurine D Miner
Journal:  Nat Rev Microbiol       Date:  2009-08-03       Impact factor: 60.633

9.  Listeria-based cancer vaccines that segregate immunogenicity from toxicity.

Authors:  Dirk G Brockstedt; Martin A Giedlin; Meredith L Leong; Keith S Bahjat; Yi Gao; William Luckett; Weiqun Liu; David N Cook; Daniel A Portnoy; Thomas W Dubensky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-13       Impact factor: 11.205

10.  Role of hemolysin for the intracellular growth of Listeria monocytogenes.

Authors:  D A Portnoy; P S Jacks; D J Hinrichs
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  10 in total

1.  A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.

Authors:  Christopher C Phelps; Stephen Vadia; Prosper N Boyaka; Sanjay Varikuti; Zayed Attia; Purnima Dubey; Abhay R Satoskar; Rodney Tweten; Stephanie Seveau
Journal:  Vaccine       Date:  2020-07-17       Impact factor: 3.641

2.  Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation.

Authors:  Kelly M Cautivo; Peri R Matatia; Carlos O Lizama; Nicholas M Mroz; Madelene W Dahlgren; Xiaofei Yu; Julia Sbierski-Kind; Marcela T Taruselli; Jeremy F Brooks; Adam Wade-Vallance; Sofia E Caryotakis; Anthony A Chang; Hong-Erh Liang; Julie Zikherman; Richard M Locksley; Ari B Molofsky
Journal:  Immunity       Date:  2022-02-08       Impact factor: 31.745

3.  Pregnancy enables antibody protection against intracellular infection.

Authors:  John J Erickson; Stephanie Archer-Hartmann; Alexander E Yarawsky; Jeanette L C Miller; Stephanie Seveau; Tzu-Yu Shao; Ashley L Severance; Hilary Miller-Handley; Yuehong Wu; Giang Pham; Brian R Wasik; Colin R Parrish; Yueh-Chiang Hu; Joseph T Y Lau; Parastoo Azadi; Andrew B Herr; Sing Sing Way
Journal:  Nature       Date:  2022-06-08       Impact factor: 69.504

Review 4.  Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications.

Authors:  Suneetha Amara; Li V Yang; Venkataswarup Tiriveedhi; Mahvish Muzaffar
Journal:  Cells       Date:  2022-06-11       Impact factor: 7.666

5.  Secondary structure of the mRNA encoding listeriolysin O is essential to establish the replicative niche of L. monocytogenes.

Authors:  Bret N Peterson; Jonathan L Portman; Ying Feng; Jeffrey Wang; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

6.  A Listeria monocytogenes-Based Vaccine Formulation Reduces Vertical Transmission and Leads to Enhanced Pup Survival in a Pregnant Neosporosis Mouse Model.

Authors:  Dennis Imhof; William Robert Pownall; Camille Monney; Anna Oevermann; Andrew Hemphill
Journal:  Vaccines (Basel)       Date:  2021-11-26

7.  Protective Immunity against Listeria monocytogenes in Rats, Provided by HCl- and NaOH-Induced Listeria monocytogenes Bacterial Ghosts (LMGs) as Vaccine Candidates.

Authors:  Seongmi Ji; Eun Sun Moon; Han Byul Noh; Hyun Jung Park; Seongdae Kim; Sung Oh; Nagarajan Vinod; Chang Won Choi; Kilhan Kwak
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

Review 8.  Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.

Authors:  Tongmeng Jiang; Tao Yang; Yingfan Chen; Yao Miao; Yajing Xu; Honglin Jiang; Mingying Yang; Chuanbin Mao
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

9.  T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.

Authors:  John C Flickinger; Jagmohan Singh; Yanki Yarman; Robert D Carlson; Joshua R Barton; Scott A Waldman; Adam E Snook
Journal:  Front Immunol       Date:  2022-03-09       Impact factor: 8.786

Review 10.  Bacteria-Based Synergistic Therapy in the Backdrop of Synthetic Biology.

Authors:  Yawei Bao; Yong Cheng; Wei Liu; Wenguang Luo; Peijie Zhou; Dong Qian
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.